|
Wed, 12/05/2018 - 21:58 |
Liquid Biopsies in SOLAR-1 Trial Predict Benefit of Alpelisib in PIK3CA-Mutant Breast Cancer |
American Associ... |
|
Fri, 05/04/2018 - 04:20 |
Lexicon Pharmaceuticals Announces Publication of New Xermelo (telotristat Ethyl) Data in Clinical Therapeutics |
Lexicon Pharmac... |
|
Wed, 02/28/2018 - 04:56 |
Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference |
Lexicon Pharmac... |
|
Tue, 01/02/2018 - 14:44 |
Lexicon Pharmaceuticals Announces Poster Presentation at ASCO GI |
Lexicon Pharmac... |
|
Thu, 09/07/2017 - 03:08 |
Lexicon Pharmaceuticals Announces Four Data Presentations at the European Society of Medical Oncology 2017 Congress |
Lexicon Pharmac... |
|
Fri, 07/21/2017 - 07:10 |
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion for XERMELO (Telotristat Ethyl) |
Lexicon Pharmac... |
|
Mon, 07/18/2016 - 23:50 |
Lexicon Announces the Validation by the European Medicine Agency of the Marketing Authorization Application for Telotristat Etiprate for the Treatment of Carcinoid Syndrome |
Lexicon Pharmac... |
|
Mon, 05/30/2016 - 10:46 |
Lexicon Announces FDA Priority Review of New Drug Application for Telotristat Etiprate for the Treatment of Carcinoid Syndrome |
Lexicon Pharmac... |
|
Wed, 03/30/2016 - 20:06 |
Lexicon Submits New Drug Application to FDA for Telotristat Etiprate for the Treatment of Carcinoid Syndrome |
Lexicon Pharmac... |
|
Tue, 03/08/2016 - 14:34 |
Lexicon Announces Telotristat Etiprate Data to Be Presented at European Neuroendocrine Tumor Society Conference |
Lexicon Pharmac... |
